Associate Director, Vaccines Markets
Boston (United States of America)
The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
Overview of CHAI's Global Vaccines Program
To ensure all children have access to effective and affordable immunization, addressing the main causes of child mortality, CHAI's Vaccines Markets Team works with vaccine manufacturers, Gavi and other global stakeholders to improve availability, affordability and diversity of supply for existing and future Gavi vaccines. In doing this, CHAI is applying the techniques it has used successfully to improve access to HIV/AIDS and malaria treatment: improving market demand transparency for individual suppliers, and working closely with these suppliers to optimize their commercial, costing and pricing strategies in low and middle income markets, to ensure availability of vaccines, keep prices in these markets affordable, yet commercially sustainable.
In addition, CHAI's vaccines markets team is working with suppliers, global partners and investors to accelerate the development of novel, high-impact vaccines such as COVID 19, TB, HIV, and others. Also, CHAI is supporting Gavi and other stakeholders to improve access to vaccines for non-Gavi and former-Gavi middle income countries, through policy as well as supplier and country guidance on vaccine access and procurement. Close collaboration with CHAI's country teams and global vaccine delivery team is critical along our areas of work.
Since 2011, CHAI has worked in this field and has negotiated price reductions for major vaccines. For example, earlier work has resulted in a reduction in the price of rotavirus vaccine by two-thirds, resulting in savings of over USD$600M for global donors and governments over 5 years and a reduction in the price of pentavalent vaccine by 45%, generating savings of $150M over 4 years. Some selected news articles about CHAI's work on access in vaccines and other areas are listed here:
WHO press release, January 2018: https://www.who.int/medicines/news/2017/Bharat-Biotech-TypbarTCV-WHO-PQ-Press-Release-Global-Final.pdf?ua=1
WHO press release, April 2013: http://www.who.int/pmnch/media/news/2013/gavi_pentavalent_price_announcement.pdf
The pandemic context has only reinforced the importance of CHAI Vaccines markets team work, coupling the need to ensure supply security for existing vaccines for which demand and supply dynamics are being disrupted, with the need to accelerate time to market of a suitable COVID vaccine on an unprecedented time frame. CHAI is working closely with many partners towards this goal.
- Manage a team of 8 full time employees (2 Managers and 6 (Sr.) Associates) on projects to improve vaccine accessibility to low-income countries based in various locations around the world (Europe, Asia, North America, Africa)
- Manage relationships with suppliers that have the potential to become significant, quality-assured producers of relevant vaccines for developing markets, including Developing Country Vaccine Manufacturers in India, China, Korea
- Build and maintain these relationships by providing valuable market insights and contacts, offering targeted business planning support (e.g. go-to-market strategies for vaccines in L/MICs, vaccine pipeline planning) and guidance to navigate regulatory and procurement processes, and ultimately strengthening their supplier sustainability and interest in L/MIC markets
- Oversee analysis on vaccine market dynamics including demand forecasting, production capacity of key manufacturers, production technologies and their costs, cost reduction strategies, product development and manufacturing timelines, and manufacturers' vaccine development and marketing strategies
- Coordinate CHAI's efforts to help accelerate equitable access to COVID-19 vaccines for LMICs, including by supporting global efforts by global partners to speed up vaccine development and manufacturing (e.g. CEPI) and vaccine access and delivery (e.g. Gavi, WHO)
- Oversee analysis of vaccine cost of goods sold and other analysis as needed in vaccine price negotiations for low-income countries
- Lead relationship management with key donors, such as the Bill and Melinda Gates Foundation, DFID, as well as with key other stakeholders, such as Gavi, UNICEF SD, WHO, PATH, Linksbridge and other organizations in the field of vaccine market dynamics.
- Lead preparations of presentations, reports, and other analyses to inform global policy and increase the evidence base for high-impact interventions to increase vaccine supply security or affordability for L/MICs and accelerate vaccine innovation
- Any other duties as required by the Director, Vaccine Markets
20-30% International travel required (when the international context allows)
Bachelor's degree and a minimum 10 years of work experience
Proven team management skills with a good eye for people development/coaching
Strong strategic/structured thinker and communicator
Exceptional problem-solving and analytical skills
Excellent verbal and written communication skills
Proven project management skills: ability to work effectively in high-pressure, fast-paced environment and handle multiple tasks simultaneously
Entrepreneurial mindset, including ability to work independently, self-motivate, and propose and implement new initiatives
Strong commitment to CHAI's and the team's mission, dedicated team player
- Experience working in the vaccines or pharmaceutical industry, finance or strategy consulting is considered a plus
- Experience living and working in L/MICs
- Familiarity with/previous exposure to actors in global health space (e.g. Gavi, Bill & Melinda Gates Foundation, UNICEF, WHO)
- Advanced degree in management, public health, science, or other relevant fields